HCM
MGNX icon

Highbridge Capital Management’s MacroGenics MGNX Stock Holding History

Highbridge Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,801
Closed -$218K – 1842
2017
Q3 		$218K Sell
11,801
-13,446
-53% -$233K ﹤0.01% 1378
2017
Q2 		$442K Buy
+25,247
New +$482K 0.01% 793
2015
Q3 		– Sell
-36,924
Closed -$1.4M – 1729
2015
Q2 		$1.4M Sell
36,924
-13,501
-27% -$444K 0.02% 625
2015
Q1 		$1.58M Buy
50,425
+37,550
+292% +$1.27M 0.02% 601
2014
Q4 		$451K Buy
+12,875
New +$321K 0.01% 852

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's MGNX Position: Q4 2017 in Review

Highbridge Capital Management sold out of MacroGenics (MGNX) in Q4 2017, closing a stake of 11,801 shares — an estimated $218K sold.

Highbridge Capital Management first reported a position in MGNX in Q4 2014 and held it in 5 quarters. The position peaked at $1.58M in Q1 2015. 119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

  • Highbridge Capital Management reported no remaining MacroGenics position as of Q4 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 11,801 MacroGenics shares in Q4 2017, an estimated $218K.
  • Highbridge Capital Management first reported a position in MacroGenics in Q4 2014 and held it in 5 quarters.
  • Highbridge Capital Management's MacroGenics position peaked at $1.58M in Q1 2015.
  • 119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.